Atlas Trials

Carcinoma, Ovarian Epithelial

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Carcinoma, Ovarian Epithelial

RecordFirmDate
Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer (NCT05158062)Kosei Hasegawa, MD, PhD2022-04-20
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). (NCT05116189)Merck Sharp & Dohme LLC2021-12-13
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166)Wenjun Cheng2021-08-24
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151)Sheba Medical Center2021-04-12
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929)Carisma Therapeutics Inc2021-02-02
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071)Xiaoxiang Chen2020-11-06
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952)Xiaoxiang Chen2020-10-28
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (NCT04498117)CanariaBio Inc.2020-08-25
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers (NCT03976999)Institut du Cancer de Montpellier - Val d'Aurelle2017-07-05

Track Carcinoma, Ovarian Epithelial automatically

Every clearance here is in the API, with alerts when new ones post.